| HOME >> BIOLOGY >> TECHNOLOGY |
Total non-current liabilities 4,805,872 6,397,742
Total liabilities 29,135,219 17,443,424
MINORITY INTEREST 6,144,063 11,883,323
SHAREHOLDERS' EQUITY:
Common stock, $0.001 par value, 250,000,000
shares authorized, 71,333,586 issued and
outstanding, respectively 71,334 71,334
Paid-in-capital 8,842,009 8,842,009
Additional paid-in-capital 69,105 --
Statutory reserves 9,420,783 9,420,783
Retained earnings 113,964,778 95,371,137
Accumulated other comprehensive income 13,980,346 5,714,988
Total shareholders' equity 146,348,355 119,420,251
Total liabilities and shareholders'
equity $ 181,627,637 $ 148,746,998
TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES
REVENUE BY REGION
Three months
ended December 31,
2007 2006 Change
China $ 6,739,641 $ 6,793,469 - 0.8%
International $ 6,575,670 $ 9,793,691 -32.9%
Total $13,315,311 $16,587,160 -19.7%
Twelve months
ended December 31,
2007 2006 Change
China $22,476,135 $27,074,979 -17.0%
International $32,423,925 $39,715,487 -18.4%
Total
'/>"/>
| SOURCE Tiens Biotech Group (USA), Inc. Copyright©2008 PR Newswire. All rights reserved |